[
  {
    "text": "PRODUCT MANUFACTURING AGREEMENT",
    "bbox": [
      490,
      145,
      843,
      155
    ],
    "label": 1,
    "category": "Document Name"
  },
  {
    "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
    "bbox": [
      110,
      176,
      1000,
      189
    ],
    "label": 2,
    "category": "Parties"
  },
  {
    "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
    "bbox": [
      112,
      193,
      784,
      205
    ],
    "label": 2,
    "category": "Parties"
  },
  {
    "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
    "bbox": [
      110,
      160,
      1000,
      173
    ],
    "label": 2,
    "category": "Parties"
  },
  {
    "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
    "bbox": [
      110,
      160,
      1000,
      173
    ],
    "label": 2,
    "category": "Parties"
  },
  {
    "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
    "bbox": [
      110,
      176,
      1000,
      189
    ],
    "label": 2,
    "category": "Parties"
  },
  {
    "text": "Exhibit 4.15",
    "bbox": [
      1000,
      80,
      1000,
      92
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
    "bbox": [
      122,
      96,
      1000,
      108
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
    "bbox": [
      160,
      113,
      1000,
      123
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "COMIMISSION.",
    "bbox": [
      606,
      129,
      727,
      140
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "PRODUCT MANUFACTURING AGREEMENT",
    "bbox": [
      490,
      145,
      843,
      155
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
    "bbox": [
      110,
      160,
      1000,
      173
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
    "bbox": [
      110,
      176,
      1000,
      189
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
    "bbox": [
      112,
      193,
      784,
      205
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
    "bbox": [
      110,
      207,
      1000,
      222
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
    "bbox": [
      221,
      226,
      983,
      236
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      241,
      207,
      251
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
    "bbox": [
      220,
      240,
      1000,
      253
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "products;",
    "bbox": [
      222,
      258,
      295,
      269
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      273,
      206,
      283
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
    "bbox": [
      221,
      273,
      1000,
      284
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
    "bbox": [
      222,
      289,
      862,
      301
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      305,
      207,
      315
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
    "bbox": [
      220,
      304,
      1000,
      317
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
    "bbox": [
      220,
      320,
      1000,
      333
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
    "bbox": [
      110,
      336,
      1000,
      349
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "follows:",
    "bbox": [
      110,
      352,
      171,
      364
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "1",
    "bbox": [
      111,
      370,
      122,
      379
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "Definitions",
    "bbox": [
      148,
      369,
      237,
      380
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
    "bbox": [
      111,
      385,
      1000,
      397
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "provided for in this Agreement or the context otherwise requires, the following:.",
    "bbox": [
      111,
      400,
      705,
      414
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "1.1",
    "bbox": [
      152,
      416,
      177,
      429
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
    "bbox": [
      220,
      415,
      1000,
      430
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "with, or in the Control of such Party..",
    "bbox": [
      222,
      432,
      492,
      445
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "1.2",
    "bbox": [
      152,
      448,
      177,
      461
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
    "bbox": [
      221,
      449,
      1000,
      461
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
    "bbox": [
      222,
      465,
      1000,
      477
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
    "bbox": [
      220,
      480,
      822,
      493
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "1.3",
    "bbox": [
      152,
      496,
      177,
      509
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
    "bbox": [
      221,
      496,
      918,
      509
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
    "bbox": [
      133,
      1000,
      506,
      1000
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "Exhibit 4.15",
    "bbox": [
      1000,
      80,
      1000,
      92
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
    "bbox": [
      122,
      96,
      1000,
      108
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
    "bbox": [
      160,
      113,
      1000,
      123
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "COMIMISSION.",
    "bbox": [
      606,
      129,
      727,
      140
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "PRODUCT MANUFACTURING AGREEMENT",
    "bbox": [
      490,
      145,
      843,
      155
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
    "bbox": [
      110,
      160,
      1000,
      173
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
    "bbox": [
      110,
      176,
      1000,
      189
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
    "bbox": [
      112,
      193,
      784,
      205
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
    "bbox": [
      110,
      207,
      1000,
      222
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
    "bbox": [
      221,
      226,
      983,
      236
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      241,
      207,
      251
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
    "bbox": [
      220,
      240,
      1000,
      253
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "products;",
    "bbox": [
      222,
      258,
      295,
      269
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      273,
      206,
      283
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
    "bbox": [
      221,
      273,
      1000,
      284
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
    "bbox": [
      222,
      289,
      862,
      301
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      305,
      207,
      315
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
    "bbox": [
      220,
      304,
      1000,
      317
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
    "bbox": [
      220,
      320,
      1000,
      333
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
    "bbox": [
      110,
      336,
      1000,
      349
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "follows:",
    "bbox": [
      110,
      352,
      171,
      364
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "1",
    "bbox": [
      111,
      370,
      122,
      379
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "Definitions",
    "bbox": [
      148,
      369,
      237,
      380
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
    "bbox": [
      111,
      385,
      1000,
      397
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "provided for in this Agreement or the context otherwise requires, the following:.",
    "bbox": [
      111,
      400,
      705,
      414
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "1.1",
    "bbox": [
      152,
      416,
      177,
      429
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
    "bbox": [
      220,
      415,
      1000,
      430
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "with, or in the Control of such Party..",
    "bbox": [
      222,
      432,
      492,
      445
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "1.2",
    "bbox": [
      152,
      448,
      177,
      461
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
    "bbox": [
      221,
      449,
      1000,
      461
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
    "bbox": [
      222,
      465,
      1000,
      477
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
    "bbox": [
      220,
      480,
      822,
      493
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "1.3",
    "bbox": [
      152,
      496,
      177,
      509
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
    "bbox": [
      221,
      496,
      918,
      509
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
    "bbox": [
      133,
      1000,
      506,
      1000
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "Exhibit 4.15",
    "bbox": [
      1000,
      80,
      1000,
      92
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
    "bbox": [
      122,
      96,
      1000,
      108
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
    "bbox": [
      160,
      113,
      1000,
      123
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "COMIMISSION.",
    "bbox": [
      606,
      129,
      727,
      140
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "PRODUCT MANUFACTURING AGREEMENT",
    "bbox": [
      490,
      145,
      843,
      155
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
    "bbox": [
      110,
      160,
      1000,
      173
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
    "bbox": [
      110,
      176,
      1000,
      189
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
    "bbox": [
      112,
      193,
      784,
      205
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
    "bbox": [
      110,
      207,
      1000,
      222
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
    "bbox": [
      221,
      226,
      983,
      236
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      241,
      207,
      251
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
    "bbox": [
      220,
      240,
      1000,
      253
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "products;",
    "bbox": [
      222,
      258,
      295,
      269
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      273,
      206,
      283
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
    "bbox": [
      221,
      273,
      1000,
      284
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
    "bbox": [
      222,
      289,
      862,
      301
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      305,
      207,
      315
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
    "bbox": [
      220,
      304,
      1000,
      317
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
    "bbox": [
      220,
      320,
      1000,
      333
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
    "bbox": [
      110,
      336,
      1000,
      349
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "follows:",
    "bbox": [
      110,
      352,
      171,
      364
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "1",
    "bbox": [
      111,
      370,
      122,
      379
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Definitions",
    "bbox": [
      148,
      369,
      237,
      380
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
    "bbox": [
      111,
      385,
      1000,
      397
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "provided for in this Agreement or the context otherwise requires, the following:.",
    "bbox": [
      111,
      400,
      705,
      414
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "1.1",
    "bbox": [
      152,
      416,
      177,
      429
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
    "bbox": [
      220,
      415,
      1000,
      430
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "with, or in the Control of such Party..",
    "bbox": [
      222,
      432,
      492,
      445
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "1.2",
    "bbox": [
      152,
      448,
      177,
      461
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
    "bbox": [
      221,
      449,
      1000,
      461
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
    "bbox": [
      222,
      465,
      1000,
      477
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
    "bbox": [
      220,
      480,
      822,
      493
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "1.3",
    "bbox": [
      152,
      496,
      177,
      509
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
    "bbox": [
      221,
      496,
      918,
      509
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
    "bbox": [
      133,
      1000,
      506,
      1000
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Exhibit 4.15",
    "bbox": [
      1000,
      80,
      1000,
      92
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
    "bbox": [
      122,
      96,
      1000,
      108
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
    "bbox": [
      160,
      113,
      1000,
      123
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "COMIMISSION.",
    "bbox": [
      606,
      129,
      727,
      140
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "PRODUCT MANUFACTURING AGREEMENT",
    "bbox": [
      490,
      145,
      843,
      155
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
    "bbox": [
      110,
      160,
      1000,
      173
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
    "bbox": [
      110,
      176,
      1000,
      189
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
    "bbox": [
      112,
      193,
      784,
      205
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
    "bbox": [
      110,
      207,
      1000,
      222
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
    "bbox": [
      221,
      226,
      983,
      236
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      241,
      207,
      251
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
    "bbox": [
      220,
      240,
      1000,
      253
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "products;",
    "bbox": [
      222,
      258,
      295,
      269
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      273,
      206,
      283
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
    "bbox": [
      221,
      273,
      1000,
      284
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
    "bbox": [
      222,
      289,
      862,
      301
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      305,
      207,
      315
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
    "bbox": [
      220,
      304,
      1000,
      317
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
    "bbox": [
      220,
      320,
      1000,
      333
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
    "bbox": [
      110,
      336,
      1000,
      349
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "follows:",
    "bbox": [
      110,
      352,
      171,
      364
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "1",
    "bbox": [
      111,
      370,
      122,
      379
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Definitions",
    "bbox": [
      148,
      369,
      237,
      380
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
    "bbox": [
      111,
      385,
      1000,
      397
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "provided for in this Agreement or the context otherwise requires, the following:.",
    "bbox": [
      111,
      400,
      705,
      414
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "1.1",
    "bbox": [
      152,
      416,
      177,
      429
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
    "bbox": [
      220,
      415,
      1000,
      430
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "with, or in the Control of such Party..",
    "bbox": [
      222,
      432,
      492,
      445
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "1.2",
    "bbox": [
      152,
      448,
      177,
      461
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
    "bbox": [
      221,
      449,
      1000,
      461
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
    "bbox": [
      222,
      465,
      1000,
      477
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
    "bbox": [
      220,
      480,
      822,
      493
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "1.3",
    "bbox": [
      152,
      496,
      177,
      509
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
    "bbox": [
      221,
      496,
      918,
      509
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
    "bbox": [
      133,
      1000,
      506,
      1000
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Exhibit 4.15",
    "bbox": [
      1000,
      80,
      1000,
      92
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
    "bbox": [
      122,
      96,
      1000,
      108
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
    "bbox": [
      160,
      113,
      1000,
      123
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "COMIMISSION.",
    "bbox": [
      606,
      129,
      727,
      140
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "PRODUCT MANUFACTURING AGREEMENT",
    "bbox": [
      490,
      145,
      843,
      155
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
    "bbox": [
      110,
      160,
      1000,
      173
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
    "bbox": [
      110,
      176,
      1000,
      189
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
    "bbox": [
      112,
      193,
      784,
      205
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
    "bbox": [
      110,
      207,
      1000,
      222
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
    "bbox": [
      221,
      226,
      983,
      236
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      241,
      207,
      251
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
    "bbox": [
      220,
      240,
      1000,
      253
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "products;",
    "bbox": [
      222,
      258,
      295,
      269
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      273,
      206,
      283
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
    "bbox": [
      221,
      273,
      1000,
      284
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
    "bbox": [
      222,
      289,
      862,
      301
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      305,
      207,
      315
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
    "bbox": [
      220,
      304,
      1000,
      317
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
    "bbox": [
      220,
      320,
      1000,
      333
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
    "bbox": [
      110,
      336,
      1000,
      349
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "follows:",
    "bbox": [
      110,
      352,
      171,
      364
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "1",
    "bbox": [
      111,
      370,
      122,
      379
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Definitions",
    "bbox": [
      148,
      369,
      237,
      380
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
    "bbox": [
      111,
      385,
      1000,
      397
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "provided for in this Agreement or the context otherwise requires, the following:.",
    "bbox": [
      111,
      400,
      705,
      414
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "1.1",
    "bbox": [
      152,
      416,
      177,
      429
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
    "bbox": [
      220,
      415,
      1000,
      430
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "with, or in the Control of such Party..",
    "bbox": [
      222,
      432,
      492,
      445
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "1.2",
    "bbox": [
      152,
      448,
      177,
      461
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
    "bbox": [
      221,
      449,
      1000,
      461
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
    "bbox": [
      222,
      465,
      1000,
      477
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
    "bbox": [
      220,
      480,
      822,
      493
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "1.3",
    "bbox": [
      152,
      496,
      177,
      509
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
    "bbox": [
      221,
      496,
      918,
      509
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
    "bbox": [
      133,
      1000,
      506,
      1000
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Exhibit 4.15",
    "bbox": [
      1000,
      80,
      1000,
      92
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
    "bbox": [
      122,
      96,
      1000,
      108
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
    "bbox": [
      160,
      113,
      1000,
      123
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "COMIMISSION.",
    "bbox": [
      606,
      129,
      727,
      140
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "PRODUCT MANUFACTURING AGREEMENT",
    "bbox": [
      490,
      145,
      843,
      155
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
    "bbox": [
      110,
      160,
      1000,
      173
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
    "bbox": [
      110,
      176,
      1000,
      189
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
    "bbox": [
      112,
      193,
      784,
      205
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
    "bbox": [
      110,
      207,
      1000,
      222
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
    "bbox": [
      221,
      226,
      983,
      236
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      241,
      207,
      251
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
    "bbox": [
      220,
      240,
      1000,
      253
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "products;",
    "bbox": [
      222,
      258,
      295,
      269
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      273,
      206,
      283
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
    "bbox": [
      221,
      273,
      1000,
      284
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
    "bbox": [
      222,
      289,
      862,
      301
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      305,
      207,
      315
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
    "bbox": [
      220,
      304,
      1000,
      317
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
    "bbox": [
      220,
      320,
      1000,
      333
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
    "bbox": [
      110,
      336,
      1000,
      349
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "follows:",
    "bbox": [
      110,
      352,
      171,
      364
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "1",
    "bbox": [
      111,
      370,
      122,
      379
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Definitions",
    "bbox": [
      148,
      369,
      237,
      380
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
    "bbox": [
      111,
      385,
      1000,
      397
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "provided for in this Agreement or the context otherwise requires, the following:.",
    "bbox": [
      111,
      400,
      705,
      414
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "1.1",
    "bbox": [
      152,
      416,
      177,
      429
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
    "bbox": [
      220,
      415,
      1000,
      430
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "with, or in the Control of such Party..",
    "bbox": [
      222,
      432,
      492,
      445
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "1.2",
    "bbox": [
      152,
      448,
      177,
      461
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
    "bbox": [
      221,
      449,
      1000,
      461
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
    "bbox": [
      222,
      465,
      1000,
      477
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
    "bbox": [
      220,
      480,
      822,
      493
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "1.3",
    "bbox": [
      152,
      496,
      177,
      509
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
    "bbox": [
      221,
      496,
      918,
      509
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
    "bbox": [
      133,
      1000,
      506,
      1000
    ],
    "label": 17,
    "category": "Change Of Control"
  },
  {
    "text": "Exhibit 4.15",
    "bbox": [
      1000,
      80,
      1000,
      92
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
    "bbox": [
      122,
      96,
      1000,
      108
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
    "bbox": [
      160,
      113,
      1000,
      123
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "COMIMISSION.",
    "bbox": [
      606,
      129,
      727,
      140
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "PRODUCT MANUFACTURING AGREEMENT",
    "bbox": [
      490,
      145,
      843,
      155
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
    "bbox": [
      110,
      160,
      1000,
      173
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
    "bbox": [
      110,
      176,
      1000,
      189
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
    "bbox": [
      112,
      193,
      784,
      205
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
    "bbox": [
      110,
      207,
      1000,
      222
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
    "bbox": [
      221,
      226,
      983,
      236
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      241,
      207,
      251
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
    "bbox": [
      220,
      240,
      1000,
      253
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "products;",
    "bbox": [
      222,
      258,
      295,
      269
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      273,
      206,
      283
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
    "bbox": [
      221,
      273,
      1000,
      284
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
    "bbox": [
      222,
      289,
      862,
      301
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      305,
      207,
      315
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
    "bbox": [
      220,
      304,
      1000,
      317
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
    "bbox": [
      220,
      320,
      1000,
      333
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
    "bbox": [
      110,
      336,
      1000,
      349
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "follows:",
    "bbox": [
      110,
      352,
      171,
      364
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1",
    "bbox": [
      111,
      370,
      122,
      379
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Definitions",
    "bbox": [
      148,
      369,
      237,
      380
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
    "bbox": [
      111,
      385,
      1000,
      397
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "provided for in this Agreement or the context otherwise requires, the following:.",
    "bbox": [
      111,
      400,
      705,
      414
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.1",
    "bbox": [
      152,
      416,
      177,
      429
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
    "bbox": [
      220,
      415,
      1000,
      430
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "with, or in the Control of such Party..",
    "bbox": [
      222,
      432,
      492,
      445
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.2",
    "bbox": [
      152,
      448,
      177,
      461
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
    "bbox": [
      221,
      449,
      1000,
      461
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
    "bbox": [
      222,
      465,
      1000,
      477
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
    "bbox": [
      220,
      480,
      822,
      493
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.3",
    "bbox": [
      152,
      496,
      177,
      509
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
    "bbox": [
      221,
      496,
      918,
      509
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
    "bbox": [
      133,
      1000,
      506,
      1000
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Exhibit 4.15",
    "bbox": [
      1000,
      80,
      1000,
      92
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
    "bbox": [
      122,
      96,
      1000,
      108
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
    "bbox": [
      160,
      113,
      1000,
      123
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "COMIMISSION.",
    "bbox": [
      606,
      129,
      727,
      140
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "PRODUCT MANUFACTURING AGREEMENT",
    "bbox": [
      490,
      145,
      843,
      155
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
    "bbox": [
      110,
      160,
      1000,
      173
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
    "bbox": [
      110,
      176,
      1000,
      189
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
    "bbox": [
      112,
      193,
      784,
      205
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
    "bbox": [
      110,
      207,
      1000,
      222
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
    "bbox": [
      221,
      226,
      983,
      236
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      241,
      207,
      251
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
    "bbox": [
      220,
      240,
      1000,
      253
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "products;",
    "bbox": [
      222,
      258,
      295,
      269
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      273,
      206,
      283
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
    "bbox": [
      221,
      273,
      1000,
      284
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
    "bbox": [
      222,
      289,
      862,
      301
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      305,
      207,
      315
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
    "bbox": [
      220,
      304,
      1000,
      317
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
    "bbox": [
      220,
      320,
      1000,
      333
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
    "bbox": [
      110,
      336,
      1000,
      349
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "follows:",
    "bbox": [
      110,
      352,
      171,
      364
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1",
    "bbox": [
      111,
      370,
      122,
      379
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Definitions",
    "bbox": [
      148,
      369,
      237,
      380
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
    "bbox": [
      111,
      385,
      1000,
      397
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "provided for in this Agreement or the context otherwise requires, the following:.",
    "bbox": [
      111,
      400,
      705,
      414
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.1",
    "bbox": [
      152,
      416,
      177,
      429
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
    "bbox": [
      220,
      415,
      1000,
      430
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "with, or in the Control of such Party..",
    "bbox": [
      222,
      432,
      492,
      445
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.2",
    "bbox": [
      152,
      448,
      177,
      461
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
    "bbox": [
      221,
      449,
      1000,
      461
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
    "bbox": [
      222,
      465,
      1000,
      477
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
    "bbox": [
      220,
      480,
      822,
      493
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.3",
    "bbox": [
      152,
      496,
      177,
      509
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
    "bbox": [
      221,
      496,
      918,
      509
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
    "bbox": [
      133,
      1000,
      506,
      1000
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Exhibit 4.15",
    "bbox": [
      1000,
      80,
      1000,
      92
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
    "bbox": [
      122,
      96,
      1000,
      108
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
    "bbox": [
      160,
      113,
      1000,
      123
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "COMIMISSION.",
    "bbox": [
      606,
      129,
      727,
      140
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "PRODUCT MANUFACTURING AGREEMENT",
    "bbox": [
      490,
      145,
      843,
      155
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
    "bbox": [
      110,
      160,
      1000,
      173
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
    "bbox": [
      110,
      176,
      1000,
      189
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
    "bbox": [
      112,
      193,
      784,
      205
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
    "bbox": [
      110,
      207,
      1000,
      222
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
    "bbox": [
      221,
      226,
      983,
      236
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      241,
      207,
      251
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
    "bbox": [
      220,
      240,
      1000,
      253
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "products;",
    "bbox": [
      222,
      258,
      295,
      269
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      273,
      206,
      283
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
    "bbox": [
      221,
      273,
      1000,
      284
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
    "bbox": [
      222,
      289,
      862,
      301
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      305,
      207,
      315
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
    "bbox": [
      220,
      304,
      1000,
      317
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
    "bbox": [
      220,
      320,
      1000,
      333
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
    "bbox": [
      110,
      336,
      1000,
      349
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "follows:",
    "bbox": [
      110,
      352,
      171,
      364
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "1",
    "bbox": [
      111,
      370,
      122,
      379
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Definitions",
    "bbox": [
      148,
      369,
      237,
      380
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
    "bbox": [
      111,
      385,
      1000,
      397
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "provided for in this Agreement or the context otherwise requires, the following:.",
    "bbox": [
      111,
      400,
      705,
      414
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "1.1",
    "bbox": [
      152,
      416,
      177,
      429
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
    "bbox": [
      220,
      415,
      1000,
      430
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "with, or in the Control of such Party..",
    "bbox": [
      222,
      432,
      492,
      445
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "1.2",
    "bbox": [
      152,
      448,
      177,
      461
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
    "bbox": [
      221,
      449,
      1000,
      461
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
    "bbox": [
      222,
      465,
      1000,
      477
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
    "bbox": [
      220,
      480,
      822,
      493
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "1.3",
    "bbox": [
      152,
      496,
      177,
      509
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
    "bbox": [
      221,
      496,
      918,
      509
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
    "bbox": [
      133,
      1000,
      506,
      1000
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Exhibit 4.15",
    "bbox": [
      1000,
      80,
      1000,
      92
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
    "bbox": [
      122,
      96,
      1000,
      108
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
    "bbox": [
      160,
      113,
      1000,
      123
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "COMIMISSION.",
    "bbox": [
      606,
      129,
      727,
      140
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "PRODUCT MANUFACTURING AGREEMENT",
    "bbox": [
      490,
      145,
      843,
      155
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
    "bbox": [
      110,
      160,
      1000,
      173
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
    "bbox": [
      110,
      176,
      1000,
      189
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
    "bbox": [
      112,
      193,
      784,
      205
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
    "bbox": [
      110,
      207,
      1000,
      222
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
    "bbox": [
      221,
      226,
      983,
      236
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      241,
      207,
      251
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
    "bbox": [
      220,
      240,
      1000,
      253
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "products;",
    "bbox": [
      222,
      258,
      295,
      269
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      273,
      206,
      283
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
    "bbox": [
      221,
      273,
      1000,
      284
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
    "bbox": [
      222,
      289,
      862,
      301
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      113,
      305,
      207,
      315
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
    "bbox": [
      220,
      304,
      1000,
      317
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
    "bbox": [
      220,
      320,
      1000,
      333
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
    "bbox": [
      110,
      336,
      1000,
      349
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "follows:",
    "bbox": [
      110,
      352,
      171,
      364
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "1",
    "bbox": [
      111,
      370,
      122,
      379
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "Definitions",
    "bbox": [
      148,
      369,
      237,
      380
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
    "bbox": [
      111,
      385,
      1000,
      397
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "provided for in this Agreement or the context otherwise requires, the following:.",
    "bbox": [
      111,
      400,
      705,
      414
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "1.1",
    "bbox": [
      152,
      416,
      177,
      429
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
    "bbox": [
      220,
      415,
      1000,
      430
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "with, or in the Control of such Party..",
    "bbox": [
      222,
      432,
      492,
      445
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "1.2",
    "bbox": [
      152,
      448,
      177,
      461
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
    "bbox": [
      221,
      449,
      1000,
      461
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
    "bbox": [
      222,
      465,
      1000,
      477
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
    "bbox": [
      220,
      480,
      822,
      493
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "1.3",
    "bbox": [
      152,
      496,
      177,
      509
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
    "bbox": [
      221,
      496,
      918,
      509
    ],
    "label": 34,
    "category": "Uncapped Liability"
  },
  {
    "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
    "bbox": [
      133,
      1000,
      506,
      1000
    ],
    "label": 34,
    "category": "Uncapped Liability"
  }
]